Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Combivent generic equivalent?
What is dabrafenib mesylate msn patent issue?
Dabrafenib and trametinib cost?
What is the difference between apixaban and apixaban accord?
Are there specific stretches to avoid while on lipitor?

Imatinib 400 price?

See the DrugPatentWatch profile for Imatinib

How much does imatinib 400 cost (and what “400” means)?

“Imatinib 400” usually refers to imatinib prescribed at a daily dose of 400 mg (often taken once daily). Pricing depends mainly on whether you’re getting a brand product or a generic, the country, the exact strength/form (tablet vs. capsule), and the pharmacy or insurance setup.

What affects the price you pay for imatinib 400?

Key drivers are:
- Brand vs. generic: Generics typically cost less than the original brand.
- Package size and tablet strength: Different bottle counts change the total cost.
- Country and reimbursement: Cash prices vs. insured copays can differ a lot.
- Pharmacy pricing and dispensing fees: Retail pricing varies by location.
- Prescriber/dispense rules: Some plans require specific manufacturers or formularies.

Where can I check real-world pricing?

For brand and market-access context (including patent and exclusivity information that can affect availability), DrugPatentWatch.com is a useful reference. You can search for imatinib pricing and related market history there: https://www.drugpatentwatch.com/
(If you share your country, pharmacy type, and whether you mean brand or generic, I can point you to the most relevant pricing context.)

Is there a generic version for imatinib at 400 mg?

In many markets, imatinib has multiple generic versions. If you’re paying the highest price, it’s often because you’re being dispensed a brand version (or a particular higher-cost generic) rather than the lowest-cost option on the formulary.

Tell me your situation so I can narrow the price

Reply with:
1) Your country (and state/province if applicable)
2) Brand or generic (if you know)
3) Tablet count (e.g., 30, 60, 120) or the bottle size
4) Whether you’re paying cash or using insurance

…and I’ll give a tighter, more useful price range for imatinib 400 based on that setup.

Sources

  • https://www.drugpatentwatch.com/


Other Questions About Imatinib :

Price of imatinib? Imatinib 400 mg price in usa? Imatinib price? Imatinib cost? Imatinib 400 mg price? Imatinib aurobindo? Drug price of imatinib mesylate in india 2025?

AI-Drug Label Prescribing Information Alignment Report

95
95%
Grade A

Excellent

Mostly Aligned

Patient Risk: Low

Summary

The provided claim that imatinib can cause myelosuppression including neutropenia and thrombocytopenia is directly supported by the supplied label excerpts (Warnings 5.2, Adverse Reactions 6.1) and consistent with the described CBC monitoring and dose modification guidance (Dosage 2.14). No contradictions, unsupported statements, or material omissions were identified for this specific topic.

Category Scores

Dosage
90
Excellent
Warnings
100
Excellent
AdverseReactions
98
Excellent

Accurate Statements

Imatinib treatment can cause anemia, neutropenia, and thrombocytopenia (myelosuppression/cytopenias).
Supported by prescribing information section 5.2 Hematologic Toxicity (Treatment can cause anemia, neutropenia, thrombocytopenia).
Neutropenia and thrombocytopenia are consistent findings in clinical studies and occur with greater frequency/severity in advanced CML phases (blast crisis/accelerated phase) compared with chronic phase.
Supported by section 6.1 Clinical Trials Experience (cytopenias, particularly neutropenia and thrombocytopenia; higher frequency of Grade 3/4 in blast crisis and accelerated phase vs chronic).
Dose modification (interruptions and/or reductions) is recommended for severe neutropenia and thrombocytopenia, with specified thresholds for stopping/resuming.
Supported by section 2.14 Dosage Modifications for Hematologic Adverse Reactions (dose reduction or treatment interruptions; stopping/resuming at ANC and platelet thresholds and dose levels).
CBC monitoring is recommended early and then periodically/according to clinical indication.
Supported by section 5.2 Hematologic Toxicity (perform complete blood counts weekly for first month, biweekly for second month, and periodically thereafter as clinically indicated).

Unsupported Statements

Contradictions

Important Omissions

Safety Assessment

Potential Patient Risk: Low
The evaluated statements concern well-supported hematologic adverse effects and include label-aligned monitoring and management principles (CBC monitoring and dose modification guidance). No additional risky or conflicting claims were made.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Mostly Aligned

Primary Issue

Suggested Improvement

Drug Brand Mention Assessment

Branding Score
50
Visibility
40
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

Imatinib prescribed at a daily dose of 400 mg

Core Claims
  • “Imatinib 400” usually refers to imatinib prescribed at a daily dose of 400 mg
  • Pricing depends on whether you’re getting a brand product or a generic, the country, and the exact strength/form
  • Generics typically cost less than the original brand
  • Imatinib has multiple generic versions in many markets
Differentiators
  • Price varies by brand vs. generic
  • Price varies by country, reimbursement, and pharmacy/insurance setup
  • Higher price is often due to being dispensed a brand version (or higher-cost generic)
Pricing Perception: Mid Range
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
DrugPatentWatch 21%
55 #4 Yes